Emerging market healthcare trends spotted by Boston Company AM
The Boston Company Asset Management has issued a White Paper report that identifies pharmaceuticals, medical technology and health care infrastructure as key drivers of investment opportunities in the emerging market healthcare sector.
The Boston Company, which is a BNY Mellon Investment Management boutique, says in its White Paper that the growth of the middle class in emerging markets is leading to invest in or provide the framework for improved healthcare services.
However, the boutique adds that identifying the companies that will benefit most from this trend requires ongoing fundamental investment research and analysis.
To read the full report click here: The Boston Company EM Healthcare Report